OpenAlex
PricingAboutJobs
Log inGet started
Work

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

HTML

Year: 2010
Type: article
Study design: Observational Study
Source: The Pharmacogenomics Journal
DOI: 10.1038/tpj.2010.28
Authors: D Wang, Y Guo, S A Wrighton, G E Cooke, W Sadee
Institutions: The Ohio State University, Eli Lilly (United States)
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: CYP3A4, intronic polymorphism, allelic expression imbalance, hepatic gene expression, statin response, atorvastatin, simvastatin, lovastatin, lipid control, pharmacogenomics, biomarkers, drug metabolism
SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, Ohio State University, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases
Awards: Pharmacogenetic Antiplatelet Strategies in CHD Patients, Pharmacogenetics of sulfamethoxazole in HIV/AIDS patients
OpenAlex ID: W2080228333
FWCI: 22.86
Cites: 59
Cited by: 564
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms